Evaluation of Platelet Activation During an Asthmatic Attack in Children
diagnosis of various diseases. Mean platelet volume (MPV) has been suggested as an indirect indicator of platelet function and activation (9, 10) . The volume of a platelet is determined when it is separated from the megakaryocyte. Some cytokines such as interleukin (IL)-3, IL-6, IL-11, granulocyte-macrophage colonystimulating factor (GM-CSF), erythropoietin and thrombopoietin may have an effect on megakaryocytes that leads to the production of more reactive and larger platelets (11) .
Platelet distribution width (PDW), another platelet activation marker, is the result of deformation in active platelets due to pseudopod formation (10) . Therefore it is accepted as a more specific platelet activation marker compared to MPV in some studies (12) . Plateletcrit (PCT) represents the percentage of the platelets in total blood volume. It may be useful in diseases with low platelet count, but large platelet diameters. In these patients, platelet functions are sufficient even if the platelet count is low due to large, active platelets (10) . When platelets are activated, the release of p-selectin from the alpha granules occurs. This then passes through the surface and accumulates in the plasma, resulting in increased levels of platelets and soluble p-selectin. Therefore, p-selectin is suggested as a marker of platelet activation, together with platelet factor 4 (PF4) and beta thromboglobulin (BTG) (13) . A recent study has revealed that patients with asthma have higher serum p-selectin levels after exercise-induced bronchoconstriction compared to healthy subjects, suggesting platelet activation in asthma patients (14) .
Studies that evaluate the relationship between MPV, PDW and some inflammatory diseases such as familial Mediterranean fever, rheumatoid arthritis and diabetes have been published. The result of these studies have revealed that MPV and PDW values change during the periods of exacerbation (15, 16) . In our study, we aimed to determine changes in MPV, PDW, PCT values and p-selectin levels of asthmatic patients during and at least 1 month after the attack and to evaluate whether these values can be used as a marker for predicting an exacerbation.
METHODS
Forty patients who admitted to our hospital with astma attack during the period of April-July 2011 were included in the study. Patients were divided into two groups as mild/moderate and severe according to the severity of asthma attacks. The enrolled patients were evaluated for age, sex, body weight, height, atopy, history of domestic animals, cigarette exposure, and concomitant symptoms of allergic rhinitis and family history of allergic disease. In order to avoid possible effect of drugs and diseases on platelet function, patients who had taken oral steroid therapy before admission and those with chronic diseases were excluded from the study.
The patients who were included in the study were evaluated according to GINA criteria (17) . In the acute stage, the presence of cough, recurrent wheezing and/or shortness of breath history, rhoncus and/or prolonged expirium on physical examination, and pulmonary function tests (PEF, FEV1) showing a decrease compared to the previous values were considered to be indicative for acute asthma attacks. Patients who were admitted with wheezing and prolonged expirium during the study period were excluded. All asthmatic patients were using either fluticasone 200 µcg or budesonide 400 µg. Two ml of blood was drawn into a tube anticoagulated with ethylenediaminetetraacetic acid and then evaluated with a hemocytometer (Abbott Cell-Dyn 3700 system, Abbott Diagnostics, Santa Clara, CA, USA) that was calibrated daily. Mean platelet volume, PDW, PCT, eosinophil and platelet counts were recorded. In order to determine the level of p-selectin, 3 ml of venous blood samples drawn into standard biochemical tubes were centrifuged for 20 minutes. The serum was separated and stored in a -80°C freezer. Inhaled steroids, inhaled short-acting β2-agonist and oral steroids were administered to patients to treat acute attacks. At least 1 month after the attack, patients were reevaluated when they were symptom free. Samples for MPV, PDW, PCT, p-selectin, eosinophil and platelet count were drawn and pulmonary function tests were performed. After the completion of the study, all sera were thawed and p-selectin levels were measured by ELISA (RayBiotech, Inc. Canada). Pulmonary function tests were performed with spirometry (Flowhandy Spirometer ZAN 100, ZAN Messgeräte GmbH, Germany). Forced expiratory volume in one second (FEV1), forced vital capacity (FVC), FEV1/ FVC and forced expiratory flow (FEF25-75) were measured. This study was supported by the Baskent University Research Fund (KA11/33). The study was approved by the Baskent University Ethics Committee and written informed consent was obtained from all subjects and their family prior to the study.
STATISTICAL ANALYSES
Statistical analysis of the data set in SPSS 17.0 statistical software (Statistical Package for Social Sciences Ver. 17.0, SSPS Inc, Chicago, IL USA) were used. The results of statistical analysis were expressed as number of observations (n), mean ± standard deviation (Mean±SD), median and minimummaximum values M (min-max). A p value <0.05 was considered statistically significant. Shapiro-Wilk's test was used to assess the normality of distributions of the variables and Levene's test was used to assess the homogeneity of variances among groups. In the comparison of mild/moderate and severe asthma attack groups, if parametric test assumptions are available two independent groups were compared by Student's t-test and correlations between variables were analysed by Pearson correlation coefficient. If assumptions are not available MannWhitney U test were used and correlations between variables were analysed by Spearman's rho correlation coefficient. T-Test Paired Samples Statistics Test and Wilcoxon Signed Rank Test were used to compare asthmatic patients during and at least 1 month after attack. Correlations between variables are evaluated by Spearman's rho correlation coefficient.
RESuLTS
Eighteen girls (45%) and 22 boys (55%) were included in the study. According to the severity of the attack, 22 of them were categorized as the mild/moderate asthma attack group (7 girls, 15 boys) and 18 as the severe asthma attack group (11 girls, 7 boys). The mean age of all children was 8.7 ± 2.6 years (range 6-16, median 8.2) and did not differ significantly between the two groups (p>0.05). When compared according to the body weight and height, there was also no statistically significant difference between the two study groups (p>0.05). The demographic features are presented in Table I .
When we analyzed all asthmatic children, the white blood cell (WBC) and polymorphonuclear leukocyte (PMNL) counts were significantly high during the attack compared to those after attack while MPV, PCT and p-selectin values were significantly low (Table II) . When the mild/moderate and severe asthma attack groups were separately evaluated, MPV and PCT levels were still significantly lower during attack (Table III) . Although statistically insignificant, p-selectin levels were lower during the attack compared to those after the attack in both groups.
During the attack, only the severe asthma attack group had a negative correlation between platelet count and FEV1 (Spearman rho= -0.475, p<0.05). When all patients were examined after the attack, PDW was positively correlated with FEV1 act (Spearman rho= 0.480, p<0.05), FVC (Spearman rho= 0.481, p<0.05), FVC act (Spearman rho= 0.472, p<0.05) and FEF25-75 (Spearman rho= 0.536, p<0.05). Considering all the patients, no correlation between MPV, PDW, PCT, p-selectin values and age at diagnosis, smoking exposure, concomitant allergic rhinitis, or family history of asthma was evident.
DISCuSSION
Recent studies have suggested that platelets play a role in the allergic inflammatory response and airway remodeling (18) (19) (20) . Identification of the presence of megakaryocytes in the lungs has been the premise of platelet studies in airway disorders (21) . It was then detected that the platelet count was higher in the lungs than in the blood and this was associated with platelet production in lungs (22) . Some studies suggest that intravascular platelet activation can be determined by measuring some chemokines such as BTG and PF-4, which are secreted by platelets (19) . Similar to studies showing platelet activation in response to allergen stimulus, increased bronchial hyperreactivity has been related to increased platelet activation in patients with asthma (20) . In our study, we questioned whether complete blood count parameters, commonly used in routine practice such as platelet count, MPV, PDW, PCT and p-selectin levels are markers of asthmatic attack. We found that MPV, PCT and p-selectin levels were significantly lower at the time of an attack compared to those at symptom-free period. On the other hand, the numbers and percentage of WBCs and PMNLs were significantly higher during an attack than those obtained during the attack-free period in our patients.
Our study revealed that MPV values were significantly lower during asthma attack compared to those obtained at least 1 month after attack in both patient groups. However, there was no correlation between MPV values and severity of attacks. We found only one study in the literature concerning MPV values in asthmatic children. In this retrospective study, comparison of platelet count and platelet volume of asthmatic children during and after attack with healthy subjects revealed no significant difference (23). However, recent studies have proposed MPV to be a marker for the diagnosis of acute exacerbations in some chronic inflammatory diseases. Similar to our study, MPV levels were found to be lower compared to those in healthy subjects during the acute attacks of familial Mediterranean fever and rheumatoid arthritis (15, 16) . The release of small volume platelets by cytokines that induce stimulation of megakaryocytes in bone marrow and/or consumption of large volume/active platelets during inflammation have been suggested as the possible (24) . Our study further supports this theory that MPV can also be a marker for acute attacks in children with asthma. We found no difference in PDW values between patients during and at least 1 month after the attack in our study.
Animal studies have revealed a positive correlation between PCT and platelet count; when the platelet counts decrease, PCT values decrease or vice versa (25) . It has been emphasized that these parameters could be markers of platelet consumption. In our study, PCT values were significantly lower during the attack compared to those obtained at least one month after the attack in both patient groups. However, despite the decreased PCT, platelet counts were higher during the attack compared to the values obtained during the attack-free period. These findings indicate that platelets with larger volume consumed due to acute inflammation result in decreased PCT even in the presence of an increased number of platelets.
volume platelets remaining in the bone marrow. Reduction of the PCT level during an attack supports the consumption of platelets. Platelet characteristics may help to predict an imminent exacerbation. Assessing platelet characteristics during a probable attack may influence treatment decisions. In addition, the increase of white blood cells and PMNL count during an attack also indicates activation of inflammation.
The most important limitation of our study was the number of patients and we therefore suggest larger and timely studies to demonstrate the clinical significance of platelet activation markers during an asthmatic attack more clearly.
In the literature, it has been reported that platelets of asthmatic patients secrete beta-thromboglobulin and platelet factor-4 after bronchial provocation (19) . A positive association between p-selectin and eosinophilic cationic protein in the nasal wash of pediatric patients with asthma suggests a common pathophysiological mechanism involving p-selectin and inflammation in asthmatic patients (26) . Another study has disclosed findings suggesting that the p-selectin on activated platelets, or acquired from plasma or endothelial cells, activates eosinophil a4b1 integrin and stimulates eosinophils to adhere to activated endothelium and move to the airway. The authors concluded that targeting p-selectin-triggered eosinophil b1 integrin activation could represent a new therapeutic approach in asthma (27) . Intrabronchial challenge of house dust mitesensitive asthmatic patients revealed a significant increase in beta-thromboglobulin and PF-4 after 30 minutes of challenge but the levels decreased and returned to normal levels after 24 hours (28) . These studies suggest that platelets are activated and the release of p-selectin increases during an asthmatic attack. However, due to timing of blood sampling, conflicting results have been observed concerning levels of beta-thromboglobulin and platelet factor-4. Since our patients are usually admitted to hospital in a relatively late period of an asthma attack, low levels of p-selectin in our study during attack compared to those after the attack may be due to this exhaustion. Drawing blood for p-selectin analysis at the very early phase of attack is necessary, if possible, in order to obtain more reliable results. Furthermore the p-selectin level of the severe attack group was higher than the mild/moderate attack group. This can be explained by parents of asthmatics in mild/moderate attack possibly neglecting the symptoms and delaying admission to the hospital, whereas parents of asthmatics with a severe attack coming to the hospital earlier. On the other hand, p-selectin was shown to increase after inhaled steroid treatment in a study, although results were not statistically significant (29) . Systemic and/or inhaled steroids given during and after the asthmatic attacks may cause increased p-selectin levels. Steroids can be responsible for these results.
A recent study found that the number of platelets in asthmatic patients during and after the attack compared to healthy subjects had no significant difference (23). Similarly, we observed no significant change in platelet count in our study when we evaluated patients during an attack and in the symptom-free period. We did not find a correlation between platelet count and the severity of the asthma attack. However, we determined that FEV1 decreases when platelet count increases in the severe asthma attack group. We therefore believe platelets play a role in inflammation and the pulmonary function test is affected.
In conclusion, we found that MPV, PCT and p-selectin levels were lower in patients during an asthmatic attack in our study. We think that low levels of mean platelet volume could be caused by activation of platelets during inflammation, which results in consumption of large volume platelets with small
